Excel Industries Ltd (EXCELINDUS)

Chemicals · Agro Chemicals · NSE · Updated 17 September 2026

By StockFin Research Team • AI-Assisted Analysis • Source: BSE/NSE Filings

₹968.85 ↓ 17.25% (1Y)

🎯 Key Takeaways

Excel Industries Ltd is navigating a strategic transition from agrochemical dependency toward higher-margin specialty chemicals and contract manufacturing, marked by capacity expansions and backward integration. While near-term agrochemical demand remains pressured, the company is de-risking operations through diversification into biocides, performance solutions, and YP derivatives, supported by new facilities and long-term agreements.
Revenue grew 4.5% QoQ to ₹294 in Q1FY27.
⚠️ Agrochemical segment remains vulnerable to monsoon variability and import competition, as highlighted in filings, with erratic rainfall directly impac

Market Cap

₹1,218

P/E Ratio

17.1

P/B Ratio

0.72

ROE

4.2%

ROCE

5.5%

Debt/Equity

0.00

Div Yield

1.42%

Promoter

51.9%

✨ Ask AI About EXCELINDUS 📊 Interactive Charts

📖 The Story

Excel Industries Ltd is navigating a strategic transition from agrochemical dependency toward higher-margin specialty chemicals and contract manufacturing, marked by capacity expansions and backward integration. While near-term agrochemical demand remains pressured, the company is de-risking operations through diversification into biocides, performance solutions, and YP derivatives, supported by new facilities and long-term agreements. Profitability is stabilizing amid input cost pressures, with margins holding firm despite revenue volatility.

📰 What's Happening

In Q1 FY27 (Jun 2026), revenue reached ₹294 crores (+5% YoY), driven by growth in contract manufacturing and non-agro segments despite monsoon-related agrochemical headwinds. The company completed a ₹40 crore specialty chemical project on schedule, securing ₹25 crore in trade advances, and commissioned a 1,265 MTPA facility slated for February 2027 launch. Management highlighted product launches in Biocides and Performance Solutions during FY27 as key growth catalysts. Earlier, in FY25-26, it secured a 5-year contract manufacturing agreement generating ₹35-40 crores annually, expanded biocide capacity (commissioned Nov 2025), and launched an R&D centre in Navi Mumbai (Oct 2025). Capex of ₹40 crores was deployed for dedicated facilities, with renewable energy contributing 49% of electricity needs and Scope 1 & 2 emissions intensity improving 19.4%.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

Metric	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	310	270	234	281	294
Operating Profit	33	21	7	12	33
OPM %	10.8%	7.7%	2.8%	4.4%	11.2%
Net Profit	34	21	8	12	29
EPS	₹26.86	₹16.85	₹6.71	₹9.77	₹23.44

Revenue shows mixed momentum, with sequential growth from ₹234 crores (Dec 2025) to ₹281 crores (Mar 2026) and ₹294 crores (Jun 2026), though still below the ₹310 crores recorded in Jun 2025. Operating margins remain resilient at 11.2% in Q1 FY27, up from 4.4% in Mar 2026, reflecting cost discipline and higher-margin contract work. Profitability dipped in FY25-26 due to input cost pressures, with PAT declining ₹5 crores YoY to ₹29 crores in Q1 FY27, but stabilized on the back of operational diversification. The company is transitioning from pure agrochemical exposure to a broader specialty chemicals and contract manufacturing model, which is expected to improve revenue visibility and margin sustainability over time.

🔮 Management Outlook & What's Next

Management expects non-agro segments to drive performance in FY27, targeting higher volumes under a long-term specialty chemical supply agreement and launching new products in Biocides and Performance Solutions. The 1,265 MTPA facility is positioned to support this shift, with management emphasizing de-risking through contract manufacturing, backward integration in Yellow Phosphorous derivatives, and R&D expansion. ESG integration remains a priority, with Scope 3 emissions mapping underway and renewable energy adoption accelerating. No formal financial guidance was provided beyond operational milestones, but the focus is clearly on structural diversification rather than short-term agrochemical recovery.

Extracted from official company announcements. Not StockFin.ai's opinion.

🏦 Balance Sheet (₹ Cr)

Item	Mar 2025	Mar 2025	Mar 2026	Mar 2026
Equity Capital	6	6	6	6
Reserves	1,584	1,582	1,802	1,697
Borrowings	14	12	11	0
Total Liabilities	1,987	1,920	2,253	2,105
Fixed Assets	426	439	433	461
Investments	1,111	1,085	1,280	1,141
Total Assets	1,987	1,920	2,253	2,105

The balance sheet shows a strengthening financial profile, with equity reserves growing from ₹1,582 crores (Mar 2025) to ₹1,802 crores (Mar 2026), while borrowings rose modestly to ₹11 crores from zero, reflecting strategic capex financing. Total assets increased to ₹2,253 crores, driven by investments in manufacturing infrastructure. The debt-equity ratio improved to 0.65% from 1.04%, indicating reduced leverage and enhanced financial flexibility. Strong cash flow generation, including ₹62 crores operating cash flow in Mar 2025, supports ongoing capex without diluting equity, while trade advances from customers signal healthy contract pipeline and working capital management.

💰 Cash Flow Statement (₹ Cr)

Item	Mar 2025	Mar 2026
Operating	+62	+53
Investing	-41	-25
Financing	-16	-27
Net Cash Flow	+4	+1

👥 Shareholding Pattern

Category	Q2FY26	Q3FY26	Q4FY26	Q1FY27
Promoters	52.7%	52.7%	52.7%	51.9%
FII	2.0%	2.0%	1.9%	1.9%
DII	7.1%	7.1%	7.1%	7.1%
Public	31.1%	30.9%	30.6%	30.6%
# Shareholders	22,593	22,084	21,703	21,439

Promoter holding remains stable at ~52.69%, indicating confidence in long-term prospects. Institutional interest is gradually increasing, with FII shareholding rising to 1.86% in Q1 FY27 from 1.86% in Q4 FY26 and DII holding steady near 7%. The growing number of public shareholders (21,439 in Q1 FY27) reflects broadening retail interest. No pledging or significant dilution was observed, and the shareholder base remains stable, with no signs of activist pressure or forced exits.

⚖️ Peer Comparison — Agro Chemicals

Company	MCap (₹ Cr)	P/E	ROCE	ROE	D/E
UPL	46,518	22.8	11.4%	6.7%	0.64
PIIND	34,364	29.5	13.3%	10.4%	0.02
SUMICHEM	22,661	39.1	23.1%	17.1%	0.00
BAYERCROP	17,729	367.3	3.3%	1.2%	0.00
SHARDACROP	6,725	10.7	25.8%	20.0%	0.00
DHANUKA	4,250	14.5	27.5%	21.2%	0.03
RALLIS	3,940	24.0	12.9%	9.7%	0.03
NACLIND	3,548	302.9	6.0%	1.8%	0.44
BHAGCHEM	3,163	115.1	6.1%	3.9%	0.33
GSPCROP	2,256	19.7	22.5%	21.9%	0.66

🔗 Peer Stock Analyses

UPL PIIND SUMICHEM BAYERCROP SHARDACROP

⚠️ Risk Factors

1. Agrochemical segment remains vulnerable to monsoon variability and import competition, as highlighted in filings, with erratic rainfall directly impacting demand. 2. Input cost inflation persists, with management citing ongoing pressure on margins despite operational improvements, particularly in raw material and energy prices. 3. Execution risk around the 1,265 MTPA facility launch and new product rollouts in Biocides and Performance Solutions, which require sustained R&D investment and market adoption. 4. Currency volatility could impact export-oriented segments, though the company’s backward integration in YP derivatives helps mitigate import dependency.

📋 Recent Filings

🧠 Analyst's Read

Excel Industries is executing a deliberate shift from cyclical agrochemicals to more resilient specialty chemicals and contract manufacturing, supported by tangible infrastructure investments and strategic partnerships. While near-term profitability faces headwinds from input costs and agro demand, the company’s backward integration, ESG commitments, and diversifying revenue streams suggest improving operational resilience. Investors should monitor execution of new capacity, margin trends in non-agro segments, and monsoon impact on agrochemical demand in the upcoming quarters.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

2 free AI queries per day.

✨ Deep Dive with AI on EXCELINDUS

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-17.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when EXCELINDUS files new disclosures

Track EXCELINDUS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track EXCELINDUS — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd